EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study

Veronica Joyce Brady, Amanda L Willig, Katerina A Christopoulos, David J Grelotti, George A Yendewa, Conall O'Cleirigh, Richard D Moore, Sonia Napravnik, Allison Webel, Heidi M Crane, Michael S Saag, Stephanie A Ruderman

AIDS and Behavior · 2025

DOI: 10.1007/s10461-025-04653-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Veronica Joyce Brady und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Cizik School of Nursing, The University of Texas Health Houston, Houston, TX, USA. veronica.j.brady@uth.tmc.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, HIV Infections, Depression, Blood Glucose. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Center for AIDS Research, University of Alabama at Birmingham.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2DM) and depressive symptoms frequently co-occur among people with HIV (PWH). Depression may impact diabetes management in PWH. This study evaluated the prevalence of concurrent T2DM and depression among PWH and the impact of depression and HIV symptoms on glycemic outcomes (hemoglobin A1c [A1c], blood glucose [BG]) among people with both HIV and T2DM. We conducted a secondary analysis in the CFAR Network of Integrated Clinical Systems, a multisite clinical cohort including a diverse population of PWH in care from July 2005 through July 2023. Linear regression and linear mixed models were used to estimate the association between depression, HIV symptoms, and glycemic outcomes (A1C, BG) at baseline and over time. Of the 18,562 PWH, 2,945 (16%) also had T2DM. PWH with T2DM were older (56 vs. 49 years) and more often non-Hispanic Black and cis-gender men. The prevalence of depression was not significantly different between PWH with or without T2DM (20% vs. 21%) although more PWH with T2DM received antidepressant medications. Among people with both HIV and T2DM, HIV baseline symptoms and depression were not associated with a change in A1c. Increases in time-updated HIV symptom scores were associated with random (non-fasting) BG levels, with each additional HIV symptom resulting in 0.8 mg/dL increase in random BG level (95% CI: 0.04-1.60, p = 0.04). The prevalence of T2DM was higher among PWH than in the general population. Although depression appears to be well managed, other factors impacting glycemic outcomes among people with both HIV and T2DM require further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HIV InfectionsDepressionBlood GlucoseHumansMaleFemaleMiddle AgedGlycated HemoglobinPrevalenceAdultCohort Studies

Stichwörter der Autor:innen

Blood glucoseDepressionHIVHemoglobin A1cType 2 Diabetes mellitus

Substanzen

Glycated HemoglobinBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Research, Cizik School of Nursing, The University of Texas Health Houston, Houston, TX, USA. veronica.j.brady@uth.tmc.edu.
  • Cizik School of Nursing, The University of Texas Health Houston, 6901 Bertner Ave., Suite 567E, Houston, TX, 77030, USA. veronica.j.brady@uth.tmc.edu.
  • Division of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Division of HIV, ID and Global Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, USA.
  • HIV Neurobehavioral Research Program, Department of Psychiatry, University of California San Diego School of Medicine, San Diego, CA, USA.
  • Department of Medicine, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University School of Medicine, Cleveland, USA.

Förderung

  • NIAID NIH HHS
  • Center for AIDS Research, University of Alabama at Birmingham

Zitieren

APA

Brady, V. J., Willig, A. L., Christopoulos, K. A., Grelotti, D. J., Yendewa, G. A., O'Cleirigh, C., Moore, R. D., Napravnik, S., Webel, A., Crane, H. M., Saag, M. S., & Ruderman, S. A. (2025). Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04653-7

Vancouver

Brady VJ, Willig AL, Christopoulos KA, Grelotti DJ, Yendewa GA, O'Cleirigh C, et al. Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04653-7

BibTeX
@article{Brady2025,
  author = {Brady, Veronica Joyce and Willig, Amanda L and Christopoulos, Katerina A and Grelotti, David J and Yendewa, George A and O'Cleirigh, Conall and Moore, Richard D and Napravnik, Sonia and Webel, Allison and Crane, Heidi M and Saag, Michael S and Ruderman, Stephanie A},
  title = {Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study},
  journal = {AIDS and Behavior},
  year = {2025},
  doi = {10.1007/s10461-025-04653-7}
}
Kostenlos starten →